カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

短時間睡眠症候群治療のグローバル市場2023：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他

■ 英語タイトル：Global Short Sleep Syndrome Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11577）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11577
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[短時間睡眠症候群治療のグローバル市場2023：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、短時間睡眠症候群治療のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の短時間睡眠症候群治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 短時間睡眠症候群治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

短時間睡眠症候群治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Merck & co.、Mylan N.V.、Paratek pharmaceuticals、Pfizer Inc.、Sanofi S.A.、Sumitomo Dainippon pharma Co. Ltd.、Takeda Pharmaceuticals Company Ltd.、Teva Pharmaceutical Industries Ltd.、Vanda Pharmaceuticals Inc.

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、短時間睡眠症候群治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な短時間睡眠症候群治療メーカーの企業概要、2019年～2022年までの短時間睡眠症候群治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な短時間睡眠症候群治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別短時間睡眠症候群治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの短時間睡眠症候群治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での短時間睡眠症候群治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および短時間睡眠症候群治療の産業チェーンを掲載しています。
・第14、15章では、短時間睡眠症候群治療の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 短時間睡眠症候群治療の概要
– 種類別分析（2018年vs2022年vs2029年）：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界の短時間睡眠症候群治療市場規模・予測
– 世界の短時間睡眠症候群治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck & co.、Mylan N.V.、Paratek pharmaceuticals、Pfizer Inc.、Sanofi S.A.、Sumitomo Dainippon pharma Co. Ltd.、Takeda Pharmaceuticals Company Ltd.、Teva Pharmaceutical Industries Ltd.、Vanda Pharmaceuticals Inc.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・短時間睡眠症候群治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・短時間睡眠症候群治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・短時間睡眠症候群治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・短時間睡眠症候群治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・短時間睡眠症候群治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Short Sleep Syndrome Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Short Sleep Syndrome Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Benzodiazepines
1.3.3 Nonbenzodiazepines
1.3.4 Antidepressants
1.3.5 Orexin Antagonist
1.3.6 Melatonin Antagonist
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Short Sleep Syndrome Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Short Sleep Syndrome Treatment Market Size & Forecast
1.5.1 Global Short Sleep Syndrome Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Short Sleep Syndrome Treatment Sales Quantity (2018-2029)
1.5.3 Global Short Sleep Syndrome Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck & co.
2.1.1 Merck & co. Details
2.1.2 Merck & co. Major Business
2.1.3 Merck & co. Short Sleep Syndrome Treatment Product and Services
2.1.4 Merck & co. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & co. Recent Developments/Updates
2.2 Mylan N.V.
2.2.1 Mylan N.V. Details
2.2.2 Mylan N.V. Major Business
2.2.3 Mylan N.V. Short Sleep Syndrome Treatment Product and Services
2.2.4 Mylan N.V. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan N.V. Recent Developments/Updates
2.3 Paratek pharmaceuticals
2.3.1 Paratek pharmaceuticals Details
2.3.2 Paratek pharmaceuticals Major Business
2.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product and Services
2.3.4 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Paratek pharmaceuticals Recent Developments/Updates
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Product and Services
2.4.4 Pfizer Inc. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Inc. Recent Developments/Updates
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Product and Services
2.5.4 Sanofi S.A. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S.A. Recent Developments/Updates
2.6 Sumitomo Dainippon pharma Co. Ltd.
2.6.1 Sumitomo Dainippon pharma Co. Ltd. Details
2.6.2 Sumitomo Dainippon pharma Co. Ltd. Major Business
2.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product and Services
2.6.4 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates
2.7 Takeda Pharmaceuticals Company Ltd.
2.7.1 Takeda Pharmaceuticals Company Ltd. Details
2.7.2 Takeda Pharmaceuticals Company Ltd. Major Business
2.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product and Services
2.7.4 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates
2.8 Teva Pharmaceutical Industries Ltd.
2.8.1 Teva Pharmaceutical Industries Ltd. Details
2.8.2 Teva Pharmaceutical Industries Ltd. Major Business
2.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product and Services
2.8.4 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.9 Vanda Pharmaceuticals Inc.
2.9.1 Vanda Pharmaceuticals Inc. Details
2.9.2 Vanda Pharmaceuticals Inc. Major Business
2.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product and Services
2.9.4 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Vanda Pharmaceuticals Inc. Recent Developments/Updates
3 Competitive Environment: Short Sleep Syndrome Treatment by Manufacturer
3.1 Global Short Sleep Syndrome Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Short Sleep Syndrome Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Short Sleep Syndrome Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Short Sleep Syndrome Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Short Sleep Syndrome Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Short Sleep Syndrome Treatment Manufacturer Market Share in 2022
3.5 Short Sleep Syndrome Treatment Market: Overall Company Footprint Analysis
3.5.1 Short Sleep Syndrome Treatment Market: Region Footprint
3.5.2 Short Sleep Syndrome Treatment Market: Company Product Type Footprint
3.5.3 Short Sleep Syndrome Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Short Sleep Syndrome Treatment Market Size by Region
4.1.1 Global Short Sleep Syndrome Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Short Sleep Syndrome Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Short Sleep Syndrome Treatment Average Price by Region (2018-2029)
4.2 North America Short Sleep Syndrome Treatment Consumption Value (2018-2029)
4.3 Europe Short Sleep Syndrome Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Short Sleep Syndrome Treatment Consumption Value (2018-2029)
4.5 South America Short Sleep Syndrome Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Short Sleep Syndrome Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
5.2 Global Short Sleep Syndrome Treatment Consumption Value by Type (2018-2029)
5.3 Global Short Sleep Syndrome Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
6.2 Global Short Sleep Syndrome Treatment Consumption Value by Application (2018-2029)
6.3 Global Short Sleep Syndrome Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
7.2 North America Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
7.3 North America Short Sleep Syndrome Treatment Market Size by Country
7.3.1 North America Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Short Sleep Syndrome Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Short Sleep Syndrome Treatment Market Size by Country
8.3.1 Europe Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Short Sleep Syndrome Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Short Sleep Syndrome Treatment Market Size by Region
9.3.1 Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Short Sleep Syndrome Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
10.2 South America Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
10.3 South America Short Sleep Syndrome Treatment Market Size by Country
10.3.1 South America Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Short Sleep Syndrome Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Short Sleep Syndrome Treatment Market Size by Country
11.3.1 Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Short Sleep Syndrome Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Short Sleep Syndrome Treatment Market Drivers
12.2 Short Sleep Syndrome Treatment Market Restraints
12.3 Short Sleep Syndrome Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Short Sleep Syndrome Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Short Sleep Syndrome Treatment
13.3 Short Sleep Syndrome Treatment Production Process
13.4 Short Sleep Syndrome Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Short Sleep Syndrome Treatment Typical Distributors
14.3 Short Sleep Syndrome Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Short Sleep Syndrome Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Short Sleep Syndrome Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & co. Major Business
Table 5. Merck & co. Short Sleep Syndrome Treatment Product and Services
Table 6. Merck & co. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & co. Recent Developments/Updates
Table 8. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 9. Mylan N.V. Major Business
Table 10. Mylan N.V. Short Sleep Syndrome Treatment Product and Services
Table 11. Mylan N.V. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mylan N.V. Recent Developments/Updates
Table 13. Paratek pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Paratek pharmaceuticals Major Business
Table 15. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product and Services
Table 16. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Paratek pharmaceuticals Recent Developments/Updates
Table 18. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Short Sleep Syndrome Treatment Product and Services
Table 21. Pfizer Inc. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Inc. Recent Developments/Updates
Table 23. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A. Major Business
Table 25. Sanofi S.A. Short Sleep Syndrome Treatment Product and Services
Table 26. Sanofi S.A. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S.A. Recent Developments/Updates
Table 28. Sumitomo Dainippon pharma Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Sumitomo Dainippon pharma Co. Ltd. Major Business
Table 30. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product and Services
Table 31. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates
Table 33. Takeda Pharmaceuticals Company Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Takeda Pharmaceuticals Company Ltd. Major Business
Table 35. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product and Services
Table 36. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates
Table 38. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical Industries Ltd. Major Business
Table 40. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product and Services
Table 41. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 43. Vanda Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Vanda Pharmaceuticals Inc. Major Business
Table 45. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product and Services
Table 46. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Vanda Pharmaceuticals Inc. Recent Developments/Updates
Table 48. Global Short Sleep Syndrome Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Short Sleep Syndrome Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Short Sleep Syndrome Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Short Sleep Syndrome Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Short Sleep Syndrome Treatment Production Site of Key Manufacturer
Table 53. Short Sleep Syndrome Treatment Market: Company Product Type Footprint
Table 54. Short Sleep Syndrome Treatment Market: Company Product Application Footprint
Table 55. Short Sleep Syndrome Treatment New Market Entrants and Barriers to Market Entry
Table 56. Short Sleep Syndrome Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Short Sleep Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Short Sleep Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Short Sleep Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Short Sleep Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Short Sleep Syndrome Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Short Sleep Syndrome Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Short Sleep Syndrome Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Short Sleep Syndrome Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Short Sleep Syndrome Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Short Sleep Syndrome Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Short Sleep Syndrome Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Short Sleep Syndrome Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Short Sleep Syndrome Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Short Sleep Syndrome Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Short Sleep Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Short Sleep Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Short Sleep Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Short Sleep Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Short Sleep Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Short Sleep Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Short Sleep Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Short Sleep Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Short Sleep Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Short Sleep Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Short Sleep Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Short Sleep Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Short Sleep Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Short Sleep Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Short Sleep Syndrome Treatment Raw Material
Table 116. Key Manufacturers of Short Sleep Syndrome Treatment Raw Materials
Table 117. Short Sleep Syndrome Treatment Typical Distributors
Table 118. Short Sleep Syndrome Treatment Typical Customers
List of Figures
Figure 1. Short Sleep Syndrome Treatment Picture
Figure 2. Global Short Sleep Syndrome Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Type in 2022
Figure 4. Benzodiazepines Examples
Figure 5. Nonbenzodiazepines Examples
Figure 6. Antidepressants Examples
Figure 7. Orexin Antagonist Examples
Figure 8. Melatonin Antagonist Examples
Figure 9. Other Examples
Figure 10. Global Short Sleep Syndrome Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Application in 2022
Figure 12. Hospital Pharmacies Examples
Figure 13. Retail Pharmacies Examples
Figure 14. Online Pharmacies Examples
Figure 15. Global Short Sleep Syndrome Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Short Sleep Syndrome Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Short Sleep Syndrome Treatment Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Short Sleep Syndrome Treatment Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Short Sleep Syndrome Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Short Sleep Syndrome Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Short Sleep Syndrome Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Short Sleep Syndrome Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Short Sleep Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Short Sleep Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Short Sleep Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Short Sleep Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Short Sleep Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Short Sleep Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Short Sleep Syndrome Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Short Sleep Syndrome Treatment Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Short Sleep Syndrome Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Short Sleep Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Short Sleep Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Short Sleep Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Short Sleep Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Short Sleep Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Short Sleep Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 57. China Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Short Sleep Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Short Sleep Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Short Sleep Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Short Sleep Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Short Sleep Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Short Sleep Syndrome Treatment Market Drivers
Figure 78. Short Sleep Syndrome Treatment Market Restraints
Figure 79. Short Sleep Syndrome Treatment Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Short Sleep Syndrome Treatment in 2022
Figure 82. Manufacturing Process Analysis of Short Sleep Syndrome Treatment
Figure 83. Short Sleep Syndrome Treatment Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source

※参考情報

短時間睡眠症候群治療について、以下にその概念を詳しく解説いたします。

短時間睡眠症候群（Short Sleep Syndrome）は、通常の睡眠時間よりも著しく短い時間で、かつ十分に活発に日常生活を送ることができる状態を指します。これは、遺伝的な要因や生活習慣とも関係しており、一般的には睡眠時間が6時間未満である場合を指すことが多いです。短期間の睡眠でも、目覚めが良く、日中の活動を支障なく行うことができるため、一般的には問題視されないこともありますが、長期的には様々な健康リスクをもたらす可能性もあります。

この症候群の特徴としては、まず第一に、遺伝的要因が挙げられます。特定の遺伝子変異がこの症候群を引き起こすことが研究によって示されています。特に、DEC2遺伝子が関連しているとされ、これにより短時間の睡眠でも心身の機能が保たれると考えられています。また、短時間睡眠を必要とする人々は、一般的には情熱的で創造的な性向を持っており、仕事や趣味に多くのエネルギーを注ぎ込むことが多いとされています。

次に、この症候群はさまざまな種類に分類されることがあります。一部の研究では、短時間睡眠症候群を持つ人々は、通常の睡眠時間である7〜8時間の睡眠を取ることができるが、必要性を感じないために意図的に短い睡眠時間に抑えるケースや、睡眠時間が極端に短くとも著しい疲労感を感じないケースなどがあるとされています。個々のタイプによって、適切なアプローチや治療法が異なるため、患者に応じた対応が求められます。

治療法については、短時間睡眠そのものを改善するというよりは、生活全般の質を向上させることが重要です。まずはライフスタイルの見直しが必要です。食事や運動、ストレス管理を通じて、身体の健康を支えることが基本となります。栄養バランスの取れた食事を心掛け、適度な運動を行い、十分な水分補給をすることが薦められます。また、睡眠環境を整えることも重要です。快適な寝具や、静かな環境を確保することで、質の高い睡眠を促すことが期待できます。

さらに、関連技術としては、睡眠の質を測定するデバイスやアプリケーションが広く利用されています。これらを用いることで、自分自身の睡眠パターンや生活習慣を把握し、必要に応じて改善することが可能になります。ウェアラブルデバイスによって、心拍数や睡眠のサイクルをモニタリングすることで、より細かなデータを得ることができ、個別のアプローチを行いやすくなるでしょう。

また、心理的要因も無視できないため、必要に応じて精神的なサポートを受けることが重要です。カウンセリングやストレス管理法を学ぶことで、より良い睡眠環境を整える助けになります。心理的なストレスが睡眠に与える影響は大きく、仕事や家庭のプレッシャーをうまくコントロールする術を身に付けることが、短時間睡眠症候群を抱える人々にとって重要な一歩となるでしょう。

医療機関での治療に関しては、場合によっては睡眠薬の処方が検討されることもあります。しかし、これは一時的な対処に過ぎず、根本的な解決には至りません。したがって、薬物療法は最終手段として位置づけるべきです。医師と相談の上、適切な方針を定めることが必要です。

最後に、短時間睡眠症候群は、その特性上、人々にさまざまな影響を及ぼす可能性があるため、自身の睡眠パターンを見極め、必要に応じた対策を講じることが重要です。短時間に眠れる能力を持っているからといって、その状態が常に健康的であるとは限りません。自己管理や周囲のサポートを通じて、より良い生活の質を維持していくことが求められるでしょう。今後、研究が進むことで、より効果的な治療法や対策が期待されますが、現段階での確かな知見を踏まえ、実生活に活かしていくことが大切です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 関節痛治療のグローバル市場2023：NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質
  • SLCトランスポーター標的薬のグローバル市場2023：利尿薬、抗うつ薬、SGLT-2阻害薬
  • CNS経口薬のグローバル市場2023：抗うつ薬、抗精神病薬、抗認知症薬、抗パーキンソン病薬、抗てんかん薬、その他
  • 自閉症スペクトラム症（ASD）治療のグローバル市場（2022年-2029年）：抗精神病薬、SSRI/抗うつ薬、興奮剤、その他
  • 月経前症候群治療のグローバル市場：鎮痛薬、抗うつ薬、経口避妊薬＆卵巣抑制薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11577 )"短時間睡眠症候群治療のグローバル市場2023：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ薬、オレキシン拮抗薬、メラトニン拮抗薬、その他" (英文：Global Short Sleep Syndrome Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。